| Where does TIPS fit in the management of patients with cirrhosis? JC García-Pagán, S Saffo, M Mandorfer, G Garcia-Tsao JHEP Reports 2 (4), 100122, 2020 | 123 | 2020 |
| SGLT2 inhibitors and cirrhosis: a unique perspective on the comanagement of diabetes mellitus and ascites S Saffo, T Taddei Clinical Liver Disease 11 (6), 141-144, 2018 | 46 | 2018 |
| Systemic management for advanced hepatocellular carcinoma: a review of the molecular pathways of carcinogenesis, current and emerging therapies, and novel treatment strategies S Saffo, TH Taddei Digestive diseases and sciences 64, 1016-1029, 2019 | 37 | 2019 |
| Recombinant R-spondin2 and Wnt3a up-and down-regulate novel target genes in C57MG mouse mammary epithelial cells B Baljinnyam, M Klauzinska, S Saffo, R Callahan, JS Rubin PLoS One 7 (1), e29455, 2012 | 24 | 2012 |
| Impact of SGLT2 inhibitors in comparison with DPP4 inhibitors on ascites and death in veterans with cirrhosis on metformin S Saffo, DE Kaplan, N Mahmud, M Serper, BV John, JS Ross, T Taddei Diabetes, Obesity and Metabolism 23 (10), 2402-2408, 2021 | 15 | 2021 |
| Evolution of care in cirrhosis: preventing hepatic decompensation through pharmacotherapy S Lee, S Saffo World Journal of Gastroenterology 29 (1), 61, 2023 | 14 | 2023 |
| Liver pathologic changes after direct-acting antiviral agent therapy and sustained virologic response in the setting of chronic hepatitis C virus infection R Celli, S Saffo, S Kamili, N Wiese, T Hayden, T Taddei, D Jain Archives of pathology & laboratory medicine 145 (4), 419-427, 2021 | 11 | 2021 |
| CD40 in endothelial cells restricts neural tissue invasion by Toxoplasma gondii JAC Portillo, J Van Grol, S Saffo, Y Lopez Corcino, M Rodriguez, BA Fox, ... Infection and immunity 87 (8), 10.1128/iai. 00868-18, 2019 | 11 | 2019 |
| SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension. S Saffo, G Garcia‐Tsao, T Taddei Journal of Diabetes 13 (3), 2021 | 9 | 2021 |
| Graft-versus-host disease after pancreatic transplantation S Saffo, C Peng, N Kibbi, N Patel, ME Robert, E Adekolu, WS Asch, ... ACG Case Reports Journal 6 (9), e00214, 2019 | 8 | 2019 |
| Changes in ascitic fluid polymorphonuclear cell count after antibiotics are associated with mortality in spontaneous bacterial peritonitis S Saffo, UK To, PP Santoiemma, M Laurito, L Haque, A Rabiee, EC Verna, ... Clinical Gastroenterology and Hepatology 20 (5), e1201-e1204, 2022 | 6 | 2022 |
| Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer. C Peng, S Saffo, M Shusterman, DJ Becker, J Berlin, PE Oberstein, ... Journal of Clinical Oncology 41 (4_suppl), 59-59, 2023 | 4 | 2023 |
| Early mechanical ventilation for grade IV hepatic encephalopathy is associated with increased mortality among patients with cirrhosis: an exploratory study S Saffo, G Garcia-Tsao Acute and Critical Care 37 (3), 355, 2022 | 4 | 2022 |
| Clinical Phenotyping and the application of Precision Medicine in MAFLD S Saffo, A Do Clinical Liver Disease, 2022 | 4 | 2022 |
| Impact of neoadjuvant chemotherapy and pretreatment biliary drainage for pancreatic head ductal adenocarcinoma S Saffo, C Peng, R Salem, T Taddei, A Nagar Digestive diseases and sciences, 1-8, 2021 | 4 | 2021 |
| Clinical research training during gastroenterology fellowship S Saffo, T Taddei Digestive diseases and sciences 67 (4), 1097-1100, 2022 | 3 | 2022 |
| Emerging concepts in the care of patients with cirrhosis and septic shock JV Jimenez, G Garcia-Tsao, S Saffo World Journal of Hepatology 15 (4), 497, 2023 | 2 | 2023 |
| Circumferential esophageal perforation resulting in tension hydropneumothorax in a patient with septic shock S Saffo, J Farrell, A Nagar Acute and Critical Care 36 (3), 264, 2021 | 2 | 2021 |
| Omission of 5-fluorouracil bolus from multidrug regimens for advanced gastrointestinal cancers: a multicenter cohort study C Peng, S Saffo, PE Oberstein, M Shusterman, C Thomas, DJ Becker, ... Journal of the National Comprehensive Cancer Network 22 (8), 521-527, 2024 | 1 | 2024 |
| RACE, ETHNICITY, AND HEPATOCELLULAR CARCINOMA IN CONNECTICUT: DISPARITIES IN INCIDENCE BUT NOT OVERALL SURVIVAL R Rossi, C Mezzacappa, A Jaffe, S Saffo, TH Taddei, M Strazzabosco HEPATOLOGY 76, S1358-S1359, 2022 | | 2022 |
